Ruchała Marek, Szczepanek Ewelina, Skiba Agnieszka, Czepczyński Rafał, Sowiński Jerzy
Department of Endocrinology, Metabolism and Internal Medicine, University of Medical Sciences, Poznan, Poland.
Neuro Endocrinol Lett. 2008 Feb;29(1):55-8.
Thyroid hemiagenesis (TH) is a rare inborn anomaly, resulting from failure of one thyroid lobe development. It is usually detected incidentally during investigation of concomitant thyroid disorders. The reported patient first presented hypothyroidism at the age of 49, when Hashimoto's thyroiditis (HT) and left thyroid lobe agenesis was diagnosed. L-thyroxine (LT4) replacement therapy restored hormonal balance. Two years later, the patient developed features of Graves' hyperthyroidism. The antithyroid pharmacotherapy by thiamazole was used. However, due to severe side-effects it was discontinued, and radioiodine treatment was applied. Four months after 131I administration, symptoms of hypothyroidism appeared, so thyroid hormone substitution was reintroduced. The patient, whose observation period has now reached 5 years, under LT4 replacement therapy, remains both clinically and biochemically euthyroid. The described case displays a very rare coincidence of hypothyroidism due to HT converted into Graves' hyperthyroidism, accompanying TH. Each of these three entities, may influence the thyroid function in a different way, hence, systematic follow-up and individual therapeutic management is required.
甲状腺半侧发育不全(TH)是一种罕见的先天性异常,由一侧甲状腺叶发育失败引起。它通常在对合并的甲状腺疾病进行检查时偶然发现。报告的该患者在49岁时首次出现甲状腺功能减退,当时被诊断为桥本甲状腺炎(HT)和左甲状腺叶缺如。左甲状腺素(LT4)替代疗法恢复了激素平衡。两年后,该患者出现了格雷夫斯甲亢的症状。使用了甲巯咪唑进行抗甲状腺药物治疗。然而,由于严重的副作用,该治疗被中断,并采用了放射性碘治疗。在给予131I四个月后,出现了甲状腺功能减退的症状,因此重新引入了甲状腺激素替代治疗。该患者的观察期现已达到5年,在LT4替代治疗下,临床和生化指标均维持甲状腺功能正常。所描述的病例显示了由于HT导致的甲状腺功能减退非常罕见地转变为格雷夫斯甲亢,并伴有TH。这三个实体中的每一个都可能以不同的方式影响甲状腺功能,因此,需要进行系统的随访和个体化的治疗管理。